CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 444 filers reported holding CRISPR THERAPEUTICS AG in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $309,015 | +109.7% | 6,808 | +159.4% | 0.00% | – |
Q2 2023 | $147,368 | +28.9% | 2,625 | +3.8% | 0.00% | – |
Q1 2023 | $114,341 | -0.5% | 2,528 | -10.6% | 0.00% | – |
Q4 2022 | $114,958 | -40.7% | 2,828 | -4.3% | 0.00% | – |
Q3 2022 | $194,000 | +12.8% | 2,954 | +4.5% | 0.00% | – |
Q2 2022 | $172,000 | -9.0% | 2,828 | -6.2% | 0.00% | – |
Q1 2022 | $189,000 | -80.3% | 3,016 | -76.2% | 0.00% | -100.0% |
Q4 2021 | $960,000 | -35.0% | 12,677 | -3.9% | 0.00% | 0.0% |
Q3 2021 | $1,478,000 | -29.6% | 13,195 | +1.7% | 0.00% | -50.0% |
Q2 2021 | $2,100,000 | +28.2% | 12,976 | -3.5% | 0.00% | 0.0% |
Q1 2021 | $1,638,000 | -15.1% | 13,441 | +6.6% | 0.00% | 0.0% |
Q4 2020 | $1,930,000 | +100.8% | 12,603 | +9.6% | 0.00% | +100.0% |
Q3 2020 | $961,000 | +20.4% | 11,500 | +5.9% | 0.00% | 0.0% |
Q2 2020 | $798,000 | -10.1% | 10,860 | -48.2% | 0.00% | 0.0% |
Q1 2020 | $888,000 | -29.1% | 20,960 | +1.9% | 0.00% | 0.0% |
Q4 2019 | $1,252,000 | +46.4% | 20,560 | -1.4% | 0.00% | 0.0% |
Q3 2019 | $855,000 | -16.2% | 20,846 | -3.7% | 0.00% | 0.0% |
Q2 2019 | $1,020,000 | +31.8% | 21,646 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $774,000 | +25.6% | 21,646 | +0.3% | 0.00% | 0.0% |
Q4 2018 | $616,000 | +142.5% | 21,586 | +277.5% | 0.00% | – |
Q3 2018 | $254,000 | -56.3% | 5,718 | -42.2% | 0.00% | -100.0% |
Q2 2018 | $581,000 | – | 9,894 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 508,558 | $82,330,000 | 27.28% |
Valiant Capital Management, L.P. | 307,700 | $49,814,000 | 3.74% |
NEA Management Company, LLC | 1,590,002 | $257,405,000 | 3.35% |
NIA IMPACT ADVISORS, LLC | 39,891 | $6,458,000 | 3.15% |
Ikarian Capital, LLC | 200,000 | $32,379,000 | 2.62% |
Soleus Capital Management, L.P. | 103,114 | $16,693,000 | 2.57% |
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 157,334 | $25,471,000 | 2.47% |
Capital Impact Advisors, LLC | 45,440 | $7,356,000 | 2.37% |
ARK Investment Management | 7,776,119 | $1,258,876,000 | 2.34% |
Sassicaia Capital Advisers LLC | 13,513 | $2,188,000 | 2.28% |